Loading…
Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews
Summary Background Factor XI (FXI) deficiency is one of the most frequent inherited disorders in Ashkenazi Jews (AJ). Two predominant founder mutations termed type II (p.Glu117Stop) and type III (p.Phe283Leu) account for most cases. Objectives To present clinical aspects of a third FXI mutation, typ...
Saved in:
Published in: | Journal of thrombosis and haemostasis 2013-04, Vol.11 (4), p.724-730 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4217-1e8a88ce8e799d54c7b5d1c83e0a8dd71302da087d983e5875bd033f61d8293b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4217-1e8a88ce8e799d54c7b5d1c83e0a8dd71302da087d983e5875bd033f61d8293b3 |
container_end_page | 730 |
container_issue | 4 |
container_start_page | 724 |
container_title | Journal of thrombosis and haemostasis |
container_volume | 11 |
creator | Peretz, H. Salomon, O. Mor‐cohen, R. Usher, S. Zucker, M. Zivelin, A. Seligsohn, U. |
description | Summary
Background
Factor XI (FXI) deficiency is one of the most frequent inherited disorders in Ashkenazi Jews (AJ). Two predominant founder mutations termed type II (p.Glu117Stop) and type III (p.Phe283Leu) account for most cases.
Objectives
To present clinical aspects of a third FXI mutation, type I (c.1716 + 1G>A), which is also prevalent in AJ and to discern a possible founder effect.
Methods
Bleeding manifestations, FXI levels and origin of members of 13 unrelated families harboring the type I mutation were determined. In addition, eight intragenic and five extragenic polymorphisms were analyzed in patients with a type I mutation, in 16 unrelated type II homozygotes, in 23 unrelated type III homozygotes and in Ashkenazi Jewish controls. Analysis of these polymorphisms enabled haplotype analysis and estimation of the age of the type I mutation.
Results
Four of 16 type I heterozygotes (25%) and 6 of 12 (50%) compound heterozygotes for type I mutation (I/II and I/III), or a type I homozygote had bleeding manifestations. Haplotype analysis disclosed that like type II and type III mutations, the type I is also an ancestral mutation. An age estimate revealed that the type I mutation occurred approximately 600 years ago. The geographic distribution of affected families suggested that there was a distinct origin of the type I mutation in Eastern Europe.
Conclusions
The rather rare type I mutation in the FXI gene is a third founder mutation in AJ. |
doi_str_mv | 10.1111/jth.12137 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1458524731</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1458524731</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4217-1e8a88ce8e799d54c7b5d1c83e0a8dd71302da087d983e5875bd033f61d8293b3</originalsourceid><addsrcrecordid>eNqF0UFr2zAUB3BRVtqs62FfYAh22Q5p9STLko-hNE1KoZcUdjOK9Dwrc-xUsgnZp6-ytB0USnWRePz4o8efkK_ALiCdy1VfXwAHoY7ICKTQY6VF_unlXQhxSj7HuGIMCsnZCTnlQggOWTYij4vdBumcrofe9L5rqW9pXyOdAtDf2CL1kZo08cFR01qMfTDNf72tva2pNUPESCtj-y7QX3PqsPLWY2t3-7xJrP9ga_56eovb-IUcV6aJeP58n5GH6fXiaja-u7-ZX03uxjbjoMaA2mhtUaMqCiczq5bSgdUCmdHOKRCMO8O0ckWaSa3k0jEhqhyc5oVYijPy45C7Cd3jkD5ern202DSmxW6IJWRSS54pAR9TwXPFtQSW6Pc3dNUNoU2L7JWUeZ4xldTPg7KhizFgVW6CX5uwK4GV-8rKVFn5r7Jkvz0nDss1ulf50lEClwew9Q3u3k8qbxezQ-QTFWudxw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1325566407</pqid></control><display><type>article</type><title>Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews</title><source>EZB Electronic Journals Library</source><creator>Peretz, H. ; Salomon, O. ; Mor‐cohen, R. ; Usher, S. ; Zucker, M. ; Zivelin, A. ; Seligsohn, U.</creator><creatorcontrib>Peretz, H. ; Salomon, O. ; Mor‐cohen, R. ; Usher, S. ; Zucker, M. ; Zivelin, A. ; Seligsohn, U.</creatorcontrib><description>Summary
Background
Factor XI (FXI) deficiency is one of the most frequent inherited disorders in Ashkenazi Jews (AJ). Two predominant founder mutations termed type II (p.Glu117Stop) and type III (p.Phe283Leu) account for most cases.
Objectives
To present clinical aspects of a third FXI mutation, type I (c.1716 + 1G>A), which is also prevalent in AJ and to discern a possible founder effect.
Methods
Bleeding manifestations, FXI levels and origin of members of 13 unrelated families harboring the type I mutation were determined. In addition, eight intragenic and five extragenic polymorphisms were analyzed in patients with a type I mutation, in 16 unrelated type II homozygotes, in 23 unrelated type III homozygotes and in Ashkenazi Jewish controls. Analysis of these polymorphisms enabled haplotype analysis and estimation of the age of the type I mutation.
Results
Four of 16 type I heterozygotes (25%) and 6 of 12 (50%) compound heterozygotes for type I mutation (I/II and I/III), or a type I homozygote had bleeding manifestations. Haplotype analysis disclosed that like type II and type III mutations, the type I is also an ancestral mutation. An age estimate revealed that the type I mutation occurred approximately 600 years ago. The geographic distribution of affected families suggested that there was a distinct origin of the type I mutation in Eastern Europe.
Conclusions
The rather rare type I mutation in the FXI gene is a third founder mutation in AJ.</description><identifier>ISSN: 1538-7933</identifier><identifier>ISSN: 1538-7836</identifier><identifier>EISSN: 1538-7836</identifier><identifier>DOI: 10.1111/jth.12137</identifier><identifier>PMID: 23332144</identifier><language>eng</language><publisher>England: Elsevier Limited</publisher><subject>Age ; Ashkenazi Jews ; factor XI ; Factor XI - genetics ; Factor XI - metabolism ; factor XI deficiency ; Factor XI Deficiency - genetics ; factor XI mutations ; Female ; Founder Effect ; Humans ; Jews - genetics ; Male ; Mutation ; Pedigree ; polymorphisms</subject><ispartof>Journal of thrombosis and haemostasis, 2013-04, Vol.11 (4), p.724-730</ispartof><rights>2013 International Society on Thrombosis and Haemostasis</rights><rights>2013 International Society on Thrombosis and Haemostasis.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4217-1e8a88ce8e799d54c7b5d1c83e0a8dd71302da087d983e5875bd033f61d8293b3</citedby><cites>FETCH-LOGICAL-c4217-1e8a88ce8e799d54c7b5d1c83e0a8dd71302da087d983e5875bd033f61d8293b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23332144$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peretz, H.</creatorcontrib><creatorcontrib>Salomon, O.</creatorcontrib><creatorcontrib>Mor‐cohen, R.</creatorcontrib><creatorcontrib>Usher, S.</creatorcontrib><creatorcontrib>Zucker, M.</creatorcontrib><creatorcontrib>Zivelin, A.</creatorcontrib><creatorcontrib>Seligsohn, U.</creatorcontrib><title>Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews</title><title>Journal of thrombosis and haemostasis</title><addtitle>J Thromb Haemost</addtitle><description>Summary
Background
Factor XI (FXI) deficiency is one of the most frequent inherited disorders in Ashkenazi Jews (AJ). Two predominant founder mutations termed type II (p.Glu117Stop) and type III (p.Phe283Leu) account for most cases.
Objectives
To present clinical aspects of a third FXI mutation, type I (c.1716 + 1G>A), which is also prevalent in AJ and to discern a possible founder effect.
Methods
Bleeding manifestations, FXI levels and origin of members of 13 unrelated families harboring the type I mutation were determined. In addition, eight intragenic and five extragenic polymorphisms were analyzed in patients with a type I mutation, in 16 unrelated type II homozygotes, in 23 unrelated type III homozygotes and in Ashkenazi Jewish controls. Analysis of these polymorphisms enabled haplotype analysis and estimation of the age of the type I mutation.
Results
Four of 16 type I heterozygotes (25%) and 6 of 12 (50%) compound heterozygotes for type I mutation (I/II and I/III), or a type I homozygote had bleeding manifestations. Haplotype analysis disclosed that like type II and type III mutations, the type I is also an ancestral mutation. An age estimate revealed that the type I mutation occurred approximately 600 years ago. The geographic distribution of affected families suggested that there was a distinct origin of the type I mutation in Eastern Europe.
Conclusions
The rather rare type I mutation in the FXI gene is a third founder mutation in AJ.</description><subject>Age</subject><subject>Ashkenazi Jews</subject><subject>factor XI</subject><subject>Factor XI - genetics</subject><subject>Factor XI - metabolism</subject><subject>factor XI deficiency</subject><subject>Factor XI Deficiency - genetics</subject><subject>factor XI mutations</subject><subject>Female</subject><subject>Founder Effect</subject><subject>Humans</subject><subject>Jews - genetics</subject><subject>Male</subject><subject>Mutation</subject><subject>Pedigree</subject><subject>polymorphisms</subject><issn>1538-7933</issn><issn>1538-7836</issn><issn>1538-7836</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqF0UFr2zAUB3BRVtqs62FfYAh22Q5p9STLko-hNE1KoZcUdjOK9Dwrc-xUsgnZp6-ytB0USnWRePz4o8efkK_ALiCdy1VfXwAHoY7ICKTQY6VF_unlXQhxSj7HuGIMCsnZCTnlQggOWTYij4vdBumcrofe9L5rqW9pXyOdAtDf2CL1kZo08cFR01qMfTDNf72tva2pNUPESCtj-y7QX3PqsPLWY2t3-7xJrP9ga_56eovb-IUcV6aJeP58n5GH6fXiaja-u7-ZX03uxjbjoMaA2mhtUaMqCiczq5bSgdUCmdHOKRCMO8O0ckWaSa3k0jEhqhyc5oVYijPy45C7Cd3jkD5ern202DSmxW6IJWRSS54pAR9TwXPFtQSW6Pc3dNUNoU2L7JWUeZ4xldTPg7KhizFgVW6CX5uwK4GV-8rKVFn5r7Jkvz0nDss1ulf50lEClwew9Q3u3k8qbxezQ-QTFWudxw</recordid><startdate>201304</startdate><enddate>201304</enddate><creator>Peretz, H.</creator><creator>Salomon, O.</creator><creator>Mor‐cohen, R.</creator><creator>Usher, S.</creator><creator>Zucker, M.</creator><creator>Zivelin, A.</creator><creator>Seligsohn, U.</creator><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>201304</creationdate><title>Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews</title><author>Peretz, H. ; Salomon, O. ; Mor‐cohen, R. ; Usher, S. ; Zucker, M. ; Zivelin, A. ; Seligsohn, U.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4217-1e8a88ce8e799d54c7b5d1c83e0a8dd71302da087d983e5875bd033f61d8293b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Age</topic><topic>Ashkenazi Jews</topic><topic>factor XI</topic><topic>Factor XI - genetics</topic><topic>Factor XI - metabolism</topic><topic>factor XI deficiency</topic><topic>Factor XI Deficiency - genetics</topic><topic>factor XI mutations</topic><topic>Female</topic><topic>Founder Effect</topic><topic>Humans</topic><topic>Jews - genetics</topic><topic>Male</topic><topic>Mutation</topic><topic>Pedigree</topic><topic>polymorphisms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peretz, H.</creatorcontrib><creatorcontrib>Salomon, O.</creatorcontrib><creatorcontrib>Mor‐cohen, R.</creatorcontrib><creatorcontrib>Usher, S.</creatorcontrib><creatorcontrib>Zucker, M.</creatorcontrib><creatorcontrib>Zivelin, A.</creatorcontrib><creatorcontrib>Seligsohn, U.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Journal of thrombosis and haemostasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peretz, H.</au><au>Salomon, O.</au><au>Mor‐cohen, R.</au><au>Usher, S.</au><au>Zucker, M.</au><au>Zivelin, A.</au><au>Seligsohn, U.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews</atitle><jtitle>Journal of thrombosis and haemostasis</jtitle><addtitle>J Thromb Haemost</addtitle><date>2013-04</date><risdate>2013</risdate><volume>11</volume><issue>4</issue><spage>724</spage><epage>730</epage><pages>724-730</pages><issn>1538-7933</issn><issn>1538-7836</issn><eissn>1538-7836</eissn><abstract>Summary
Background
Factor XI (FXI) deficiency is one of the most frequent inherited disorders in Ashkenazi Jews (AJ). Two predominant founder mutations termed type II (p.Glu117Stop) and type III (p.Phe283Leu) account for most cases.
Objectives
To present clinical aspects of a third FXI mutation, type I (c.1716 + 1G>A), which is also prevalent in AJ and to discern a possible founder effect.
Methods
Bleeding manifestations, FXI levels and origin of members of 13 unrelated families harboring the type I mutation were determined. In addition, eight intragenic and five extragenic polymorphisms were analyzed in patients with a type I mutation, in 16 unrelated type II homozygotes, in 23 unrelated type III homozygotes and in Ashkenazi Jewish controls. Analysis of these polymorphisms enabled haplotype analysis and estimation of the age of the type I mutation.
Results
Four of 16 type I heterozygotes (25%) and 6 of 12 (50%) compound heterozygotes for type I mutation (I/II and I/III), or a type I homozygote had bleeding manifestations. Haplotype analysis disclosed that like type II and type III mutations, the type I is also an ancestral mutation. An age estimate revealed that the type I mutation occurred approximately 600 years ago. The geographic distribution of affected families suggested that there was a distinct origin of the type I mutation in Eastern Europe.
Conclusions
The rather rare type I mutation in the FXI gene is a third founder mutation in AJ.</abstract><cop>England</cop><pub>Elsevier Limited</pub><pmid>23332144</pmid><doi>10.1111/jth.12137</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1538-7933 |
ispartof | Journal of thrombosis and haemostasis, 2013-04, Vol.11 (4), p.724-730 |
issn | 1538-7933 1538-7836 1538-7836 |
language | eng |
recordid | cdi_proquest_miscellaneous_1458524731 |
source | EZB Electronic Journals Library |
subjects | Age Ashkenazi Jews factor XI Factor XI - genetics Factor XI - metabolism factor XI deficiency Factor XI Deficiency - genetics factor XI mutations Female Founder Effect Humans Jews - genetics Male Mutation Pedigree polymorphisms |
title | Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T13%3A18%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Type%20I%20mutation%20in%20the%20F11%20gene%20is%20a%20third%20ancestral%20mutation%20which%20causes%20factor%20XI%20deficiency%20in%20Ashkenazi%20Jews&rft.jtitle=Journal%20of%20thrombosis%20and%20haemostasis&rft.au=Peretz,%20H.&rft.date=2013-04&rft.volume=11&rft.issue=4&rft.spage=724&rft.epage=730&rft.pages=724-730&rft.issn=1538-7933&rft.eissn=1538-7836&rft_id=info:doi/10.1111/jth.12137&rft_dat=%3Cproquest_cross%3E1458524731%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4217-1e8a88ce8e799d54c7b5d1c83e0a8dd71302da087d983e5875bd033f61d8293b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1325566407&rft_id=info:pmid/23332144&rfr_iscdi=true |